Many patients denied approval for PCSK9 inhibitor therapy

from Google Alert at http://bit.ly/2gWjfwX on October 31, 2017 at 01:30AM


… atherosclerotic CVD, according to Gregory P. Hess, MD, MSc, senior fellow of health economics at the University of Pennsylvania, and colleagues.